Joshua T.

Extend Fertility was founded on the premise that democratizing egg freezing could ultimately change the fertility industry and deliver better results. Our co-founder, Dr. Joshua Klein, was a reproductive endocrinologist and fertility specialist at one of the nation’s leading fertility practices. However, he observed that IVF’s low success rate for women over 40 and its high cost was disappointing for doctors and patients alike. Dr. Klein saw the opportunity to help women think more proactively about their fertility. He believed that if more women could access their younger eggs during the IVF process, more women would see successful outcomes. Since our founding, we have helped thousands of patients on their fertility journey through egg freezing and IVF – putting them in charge of their fertility future instead of letting time dictate the path. Extend Fertility began offering egg freezing at 40% below the national average cost. By 2017, we were the largest egg freezing practice in the nation. Since then, we have expanded to offer a full range of infertility services, including IVF, in a small practice environment that is more personal, higher quality and data driven. We believe that no one should fear what they don’t know about their own fertility. We share a passion for delivering fertility in a more caring and transparent way. Because ultimately, what we do every day has the potential to change lives.

Horizon Capital (formerly known as Oryzn Capital) is a Tel Aviv-based early-stage venture capital firm, founded in 2012 by Yaniv Jacobi and Lior Segal. We specialize in supporting Israeli-founded startups in Software, AI, and subscription-based companies. With a portfolio of 20 investments, our investments have yielded 2 unicorns, 4 successful exits, and 6 companies advancing to Series A or beyond. In 2023, Horizon Capital was recognized as one of Israels most active venture capital funds for early-stage startups. Over the past decade, we have developed a proven methodology known as the Evolver Program to help our founders master uncertainty. This comprehensive operational program collaborates with our founders to build essential infrastructures, tackling the challenges of achieving the optimal product-market fit and crossing the "valley of death." Our startups achieved a 100% success rate in advancing from Seed to Series A. Additionally, we have established a professional Learning Hub for first-time entrepreneurs to bridge the knowledge gap, saving them time and effort and our Founders Space Community provides an inner network to support both personal and professional needs in real-time. Looking for your first big investment? Lets talk!

Extend Fertility was founded on the premise that democratizing egg freezing could ultimately change the fertility industry and deliver better results. Our co-founder, Dr. Joshua Klein, was a reproductive endocrinologist and fertility specialist at one of the nation’s leading fertility practices. However, he observed that IVF’s low success rate for women over 40 and its high cost was disappointing for doctors and patients alike. Dr. Klein saw the opportunity to help women think more proactively about their fertility. He believed that if more women could access their younger eggs during the IVF process, more women would see successful outcomes. Since our founding, we have helped thousands of patients on their fertility journey through egg freezing and IVF – putting them in charge of their fertility future instead of letting time dictate the path. Extend Fertility began offering egg freezing at 40% below the national average cost. By 2017, we were the largest egg freezing practice in the nation. Since then, we have expanded to offer a full range of infertility services, including IVF, in a small practice environment that is more personal, higher quality and data driven. We believe that no one should fear what they don’t know about their own fertility. We share a passion for delivering fertility in a more caring and transparent way. Because ultimately, what we do every day has the potential to change lives.

New Holland Capital is an alternative investment manager that oversees approximately $6B in discretionary absolute return investment strategies for institutional clients.